Night shift work disrupts the natural 24-hour rhythms in the activity of certain cancer-related genes, making workers more vulnerable to damage to their DNA.
On the looming 10th anniversary of the Fukushima disaster at the Daiichi Power Station in Japan, PNNL looks back at the science and solidarity it has shared with Fukushima and its nuclear cleanup effort.
Fifty-eight PNNL staff members were recognized as members of enterprise-wide teams that helped address challenges in national health and security through transformative science and technology solutions.
In a first-of-its-kind study, PNNL scientists are learning about how e-cigarettes can lead to changes in proteins at the molecular level that could contribute to disease or other health problems.
A new review paper led by senior research scientist Chun-Long Chen and featured on the cover of Accounts of Chemical Research summarizes advances by PNNL scientists in developing sequence-defined peptoids.
PNNL computational biologists, structural biologists, and analytical chemists are using their expertise to safely accelerate the design step of the COVID-19 drug discovery process.
Microbiome and soil chemistry characterization at long-term bioenergy research sites challenges idea that switchgrass increases carbon accrual in surface soils of marginal lands.
Beginning in 2021, PNNL chemical physicist Bruce Kay begins a three-year term as an AVS trustee, part of a six-member committee responsible for overseeing the administration of student scholarships and major society awards.
As COVID-19 was limiting in-person contact, halting travel, and creating additional barriers, researchers at PNNL were working to find solutions on how they could still get work done while establishing new safety protocols.